MDS, a malignant clonal stem/progenitor cell disorder originating from CD34+ cells, primarily impacts individuals over 65 years old, with a global incidence rate ranging from 2 to 12 per 100,000 individuals [21]. This evidence concerns the gene CD34 and myelodysplastic syndrome.